Hepatect CP

Hepatect

Hepatect CP contains 50 mg/ml of human plasma protein consisting of at least 96% immunoglobulin G (IgG). The hepatitis B antibody content is 50 IU/ml. Hepatitis B is an inflammation of the liver caused by the hepatitis B virus.

Haemoctin

Haemoctin

Haemoctin is a clotting factor VIII concentrate derived from blood plasma, used for the treatment and prevention of bleeding in patients with hemophilia A.

Pentaglobin

Pentaglobin

Pentaglobin is administered in severe bacterial infections in addition to antibiotic therapy. Early administration of Pentaglobin yields a significantly better result in patients with severe bacterial infections. contains up to 16 times higher titers against clinically relevant pathogens than a standard immunoglobulin preparation (see figure below).

Albiomin

Albiomin

Human albumin, a solution for infusion. Albiomin 5% (50 g/l) is a solution for intravenous infusion. One liter of the solution contains 50 g of human plasma protein, of which at least 96% is human albumin.

Zutectra

Zutectra

Human hepatitis B immunoglobulin

The active substance is human hepatitis B immunoglobulin 500 IU/ml.

Zutectra contains 150 mg/ml human plasma protein, of which at least 96% is immunoglobulin G (IgG).

Haemonine

haemonine

Haemonine is prescribed to stop or prevent bleeding due to a deficiency of factor IX (hemophilia B) in the blood of adults, adolescents, and children aged 6 years and over.

Intratect

intratect

The active ingredient of Intratect is human immunoglobulin for intravenous administration. Intratect contains 50 g/l or 100 g/l of human normal immunoglobulin, of which at least 96 % is immunoglobulin G (IgG).